Gambling and Brief Interventions

Sponsor
UConn Health (Other)
Overall Status
Completed
CT.gov ID
NCT00183599
Collaborator
Donaghue Medical Research Foundation (Other)
500
6
3
95
83.3
0.9

Study Details

Study Description

Brief Summary

This study will compare four different combinations and durations of motivational enhancement therapy, cognitive behavioral therapy, and brief advice treatments for gambling versus a non-intervention condition to determine which is most effective in reducing problem gambling.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: 5 Minutes of Simple Advice
  • Behavioral: Motivational Enhancement Therapy (MET)
  • Behavioral: Cognitive Behavioral Therapy (CBT)
N/A

Detailed Description

Gambling, if done compulsively, can cause psychological, physical, social, and vocational problems. Problem gambling, or compulsive gambling, is a progressive addiction characterized by a preoccupation with gambling, a need to bet more money more frequently, restlessness or irritability when attempting to stop, and gambling more to make up for losses. This study will compare four different combinations and durations of motivational enhancement therapy (MET), cognitive behavioral therapy (CBT), and brief advice treatments for gambling versus a non-intervention condition to determine which is most effective in reducing problem gambling.

This open-label study will last a total of 9 months. Participants will be randomly assigned to one of four groups. Group 1 will have no intervention and will be instructed to call if they experience any gambling problems. Group 2 will receive 5 minutes of education on the hazards of heavy gambling. In addition, they will receive a 1-page brochure on problem gambling and its consequences. Group 3 will receive a 1-hour session of MET focused on increasing commitment to change by raising awareness of personal consequences of gambling. Group 4 will receive the same MET session as Group 3, as well as three 1-hour sessions of CBT focused on identifying specific social and mood cues associated with gambling. Treatment will end at Week 4. Participants will have two follow-up sessions held over the phone at Week 6 and again 9 months after enrollment. Gambling behavior, employment status, alcohol and drug use, psychiatric problems, and family problems will be assessed.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of Type and Duration of Therapy on Treatment for Gambling
Study Start Date :
Apr 1, 1999
Actual Primary Completion Date :
Mar 1, 2007
Actual Study Completion Date :
Mar 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Behavioral: 5 Minutes of Simple Advice

Experimental: 2

Behavioral: Motivational Enhancement Therapy (MET)

Experimental: 3

Behavioral: Cognitive Behavioral Therapy (CBT)

Outcome Measures

Primary Outcome Measures

  1. Addiction Severity Index (ASI)-gambling severity scores [measured at baseline, Week 6, and 9 months]

  2. Amount spent gambling [measured at baseline, Week 6, and 9 months]

  3. Days gambled [measured at baseline, Week 6, and 9 months]

  4. Proportion meeting problem gambling criteria [measured at baseline, Week 6, and 9 months]

  5. Proportion abstinent [measured at baseline, Week 6, and 9 months]

Secondary Outcome Measures

  1. Psychosocial functioning [measured at baseline, Week 6, and 9 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Meets criteria for problem gambling

  • Two or more gambling episodes per month for 2 months prior to enrollment

  • Has spent at least $50 per month on gambling for 2 months prior to enrollment

Exclusion Criteria:
  • Any uncontrolled psychiatric conditions

  • Severe cognitive impairment

  • Currently receiving treatment for gambling

Contacts and Locations

Locations

Site City State Country Postal Code
1 LMG Bridgeport Connecticut United States 06604
2 University of Connecticut Health Center Farmington Connecticut United States 06030
3 CSAC Hartford Connecticut United States
4 Southern CT State University New Haven Connecticut United States 06515
5 LMG Stamford Connecticut United States
6 University of Connecticut Storrs Connecticut United States 06269

Sponsors and Collaborators

  • UConn Health
  • Donaghue Medical Research Foundation

Investigators

  • Principal Investigator: Nancy M Petry, PhD, UConn Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
UConn Health
ClinicalTrials.gov Identifier:
NCT00183599
Other Study ID Numbers:
  • 99-205
  • DF#00-121
First Posted:
Sep 16, 2005
Last Update Posted:
Apr 9, 2019
Last Verified:
Apr 1, 2019
Keywords provided by UConn Health
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 9, 2019